Multimodal Bone Fragility Profiling in People Living with HIV: Trabecular Bone Score, Calcaneal Quantitative Ultrasound, and Sarcopenia Screening

<i>Background and Objectives:</i> Bone fragility in people living with HIV (PLWH) reflects both reduced bone mineral density (BMD) and impaired microarchitecture, while functional decline may further amplify fracture vulnerability. This study evaluated whether adding a pragmatic sarcopenia screen improves bone fragility characterization beyond DXA-BMD, trabecular bone score (TBS), calcaneal quantitative ultrasound (QUS), and biomarkers, and explored the relationship between tenofovir disoproxil fumarate (TDF) exposure and microarchitectural impairment. <i>Materials and Methods:</i> In this single-center cross-sectional study at Victor Babeș University of Medicine and Pharmacy Timișoara, 98 adults on stable ART underwent DXA (T-scores), lumbar TBS (reported as TBS × 100), calcaneal QUS (SOS/BUA), and bone turnover markers (CTX, P1NP, 25(OH)D). Sarcopenia screening used handgrip strength and 4 m gait speed. Associations were tested using group comparisons, correlations, and multivariable modeling for degraded TBS (TBS × 100 < 124.0). <i>Results:</i> Sarcopenia screen-positive participants (<i>n</i> = 28) had lower TBS (123.8 vs. 127.7, <i>p</i> = 0.02), lower lumbar T-score (-1.7 vs. -1.2, <i>p</i> = 0.014), lower SOS (1523.3 vs. 1548.8 m/s, <i>p</i> = 0.002), and higher CTX (0.6 vs. 0.4 ng/mL, <i>p</i> < 0.001), with less frequent viral suppression (60.7% vs. 85.7%, <i>p</i> = 0.006). With >5 years TDF exposure (<i>n</i> = 28), degraded TBS prevalence was 82.1% vs. 40.0% in never-exposed (<i>p</i> = 0.001), alongside lower TBS (123.1 vs. 129.8, <i>p</i> < 0.001) and higher CTX (0.6 vs. 0.4 ng/mL, <i>p</i> < 0.001). Viral suppression independently reduced odds of degraded TBS (aOR 0.3, 95% CI 0.1-0.9; <i>p</i> = 0.034). <i>Conclusions:</i> In PLWH, prolonged TDF exposure and functional impairment co-occur with worse densitometric and microarchitectural profiles; viral suppression shows an independent protective association with microarchitecture.

Authors

Institutions

Publication Details

Journal
Medicina
Published
2026-03-23
DOI
https://doi.org/10.3390/medicina62030603
Primary Topic
HIV-related health complications and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multimodal Bone Fragility Profiling in People Living with HIV: Trabecular Bone Score, Calcaneal Quantitative Ultrasound, and Sarcopenia Screening

Camelia Gurban, Iulia Bogdan, David Vladut Razvan, Livia Stanga et al.
Medicina
HIV-related health complications and treatments
article

Multimodal Bone Fragility Profiling in People Living with HIV: Trabecular Bone Score, Calcaneal Quantitative Ultrasound, and Sarcopenia Screening

Camelia Gurban, Iulia Bogdan, David Vladut Razvan, Livia Stanga, Jenel Marian Patrascu, Adrian Vlad, Ovidiu Rosca
article en

Abstract

<i>Background and Objectives:</i> Bone fragility in people living with HIV (PLWH) reflects both reduced bone mineral density (BMD) and impaired microarchitecture, while functional decline may further amplify fracture vulnerability. This study evaluated whether adding a pragmatic sarcopenia screen improves bone fragility characterization beyond DXA-BMD, trabecular bone score (TBS), calcaneal quantitative ultrasound (QUS), and biomarkers, and explored the relationship between tenofovir disoproxil fumarate (TDF) exposure and microarchitectural impairment. <i>Materials and Methods:</i> In this single-center cross-sectional study at Victor Babeș University of Medicine and Pharmacy Timișoara, 98 adults on stable ART underwent DXA (T-scores), lumbar TBS (reported as TBS × 100), calcaneal QUS (SOS/BUA), and bone turnover markers (CTX, P1NP, 25(OH)D). Sarcopenia screening used handgrip strength and 4 m gait speed. Associations were tested using group comparisons, correlations, and multivariable modeling for degraded TBS (TBS × 100 < 124.0). <i>Results:</i> Sarcopenia screen-positive participants (<i>n</i> = 28) had lower TBS (123.8 vs. 127.7, <i>p</i> = 0.02), lower lumbar T-score (-1.7 vs. -1.2, <i>p</i> = 0.014), lower SOS (1523.3 vs. 1548.8 m/s, <i>p</i> = 0.002), and higher CTX (0.6 vs. 0.4 ng/mL, <i>p</i> < 0.001), with less frequent viral suppression (60.7% vs. 85.7%, <i>p</i> = 0.006). With >5 years TDF exposure (<i>n</i> = 28), degraded TBS prevalence was 82.1% vs. 40.0% in never-exposed (<i>p</i> = 0.001), alongside lower TBS (123.1 vs. 129.8, <i>p</i> < 0.001) and higher CTX (0.6 vs. 0.4 ng/mL, <i>p</i> < 0.001). Viral suppression independently reduced odds of degraded TBS (aOR 0.3, 95% CI 0.1-0.9; <i>p</i> = 0.034). <i>Conclusions:</i> In PLWH, prolonged TDF exposure and functional impairment co-occur with worse densitometric and microarchitectural profiles; viral suppression shows an independent protective association with microarchitecture.

MedicinaVol. 62(3)
Spitalul Clinic Judeţean de Urgenţă "Pius Brînzeu" Timişoara (RO), Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
Good health and well-being
Openalex Percentile: Top 16%
HIV-related health complications and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.